These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


949 related items for PubMed ID: 19898900

  • 1. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

  • 2. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
    Hayashi M, Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S, Kodera Y.
    J Surg Oncol; 2012 Mar 15; 105(4):381-6. PubMed ID: 22052684
    [Abstract] [Full Text] [Related]

  • 3. Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.
    Okamura Y, Nomoto S, Kanda M, Li Q, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A.
    Cancer Lett; 2010 Mar 28; 289(2):170-7. PubMed ID: 19733004
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS.
    Ann Surg Oncol; 2008 Dec 28; 15(12):3494-502. PubMed ID: 18830757
    [Abstract] [Full Text] [Related]

  • 5. Reduced expression of reelin (RELN) gene is associated with high recurrence rate of hepatocellular carcinoma.
    Okamura Y, Nomoto S, Kanda M, Hayashi M, Nishikawa Y, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2011 Feb 28; 18(2):572-9. PubMed ID: 20734148
    [Abstract] [Full Text] [Related]

  • 6. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC.
    Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529
    [Abstract] [Full Text] [Related]

  • 7. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S, Yeo W, Tang MW, Wong N, Lai PB, Johnson PJ.
    Clin Cancer Res; 2003 Aug 15; 9(9):3376-82. PubMed ID: 12960125
    [Abstract] [Full Text] [Related]

  • 8. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N.
    Cancer Res; 2008 Aug 15; 68(16):6743-51. PubMed ID: 18701499
    [Abstract] [Full Text] [Related]

  • 9. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.
    Genes Chromosomes Cancer; 2009 Dec 15; 48(12):1057-68. PubMed ID: 19760608
    [Abstract] [Full Text] [Related]

  • 10. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T, Iizuka N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M.
    Int J Oncol; 2008 Nov 15; 33(5):949-58. PubMed ID: 18949357
    [Abstract] [Full Text] [Related]

  • 11. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH, Wu DC, Tsai CY, Kuo TJ, Yu WC, Chang YS, Chen CL, Chang CF, Chen DS, Chen PJ.
    Clin Cancer Res; 2006 Feb 15; 12(4):1097-108. PubMed ID: 16489062
    [Abstract] [Full Text] [Related]

  • 12. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.
    Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447
    [Abstract] [Full Text] [Related]

  • 13. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
    Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A.
    Liver Int; 2005 Apr 02; 25(2):380-8. PubMed ID: 15780064
    [Abstract] [Full Text] [Related]

  • 14. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW.
    Cancer; 2006 Aug 01; 107(3):579-90. PubMed ID: 16795071
    [Abstract] [Full Text] [Related]

  • 15. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP, Zhou HJ, Chen XP, Ren GY, Ruan XX, Zhang Y, Zhang RL, Chen J.
    J Exp Clin Cancer Res; 2007 Mar 01; 26(1):117-24. PubMed ID: 17550140
    [Abstract] [Full Text] [Related]

  • 16. Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma.
    Sakai M, Hibi K, Kanazumi N, Nomoto S, Inoue S, Takeda S, Nakao A.
    Hepatogastroenterology; 2005 Mar 01; 52(66):1854-7. PubMed ID: 16334792
    [Abstract] [Full Text] [Related]

  • 17. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 18. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI.
    Gastroenterology; 2010 May 15; 138(5):1898-908. PubMed ID: 20038433
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.
    Gastroenterology; 2008 Dec 15; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [Abstract] [Full Text] [Related]

  • 20. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X, Peng JX, Hao XY, Cai JP, Liang LJ, Zhai JM, Zhang KS, Lai JM, Yin XY.
    Ann Surg Oncol; 2014 Nov 15; 21(12):3891-9. PubMed ID: 24306662
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 48.